Published in J Natl Compr Canc Netw on February 01, 2012
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA (2015) 6.38
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. Blood (2015) 1.99
Screening mammography in older women: a review. JAMA (2014) 1.70
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. Blood (2014) 1.11
Squamous cell carcinoma of the head and neck in the elderly. Rep Pract Oncol Radiother (2012) 0.98
Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review. Ann Oncol (2013) 0.97
Prevalence and factors associated with polypharmacy in older people with cancer. Support Care Cancer (2014) 0.92
Bladder cancer in the elderly patient: challenges and solutions. Clin Interv Aging (2015) 0.91
Polypharmacy cut-points in older people with cancer: how many medications are too many? Support Care Cancer (2015) 0.86
Prevalence of aging population in the Middle East and its implications on cancer incidence and care. Ann Oncol (2013) 0.84
Ageism and its clinical impact in oncogeriatry: state of knowledge and therapeutic leads. Clin Interv Aging (2014) 0.81
Incidence of chemotherapy discontinuation and characteristics of elderly patients with non-small cell lung cancer treated with platinum-based doublets. Contemp Oncol (Pozn) (2014) 0.80
Breast cancer survivorship symptom management: current perspective and future development. Breast Cancer Manag (2013) 0.79
Research priorities in geriatric oncology for 2013 and beyond. Cancer Forum (2013) 0.79
The Crossroads of Geriatric Cardiology and Cardio-Oncology. Curr Geriatr Rep (2015) 0.78
Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults. J Geriatr Oncol (2015) 0.77
Chronic Myelogenous Leukemia (CML) in the elderly. Mediterr J Hematol Infect Dis (2014) 0.77
Predicting 5- and 10-year survival in older women with early-stage breast cancer: self-rated health and walking ability. J Am Geriatr Soc (2015) 0.76
Innovative approach to older patients with malignant hemopathies. Haematologica (2016) 0.75
Gaps in nutritional research among older adults with cancer. J Geriatr Oncol (2016) 0.75
Frailty measure is more predictive of outcomes after curative therapy for endometrial cancer than traditional risk factors in women 60 and older. Gynecol Oncol (2017) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res (1983) 41.26
STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA (1963) 38.91
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med (2005) 33.60
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med (2004) 32.09
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med (2005) 28.25
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med (2007) 24.19
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol (2008) 20.89
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet (2010) 19.74
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA (2011) 16.68
Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med (1990) 16.54
The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32
Gait speed and survival in older adults. JAMA (2011) 15.01
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med (2003) 13.99
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med (2003) 13.47
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med (2008) 13.06
Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA (1993) 12.83
Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med (2008) 11.86
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med (2003) 11.35
Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol (2007) 11.04
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol (2009) 10.52
Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA (2005) 10.16
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med (2007) 10.06
Cancer screening in elderly patients: a framework for individualized decision making. JAMA (2001) 9.79
Delirium in older persons. N Engl J Med (2006) 9.70
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med (2004) 9.55
Cumulative illness rating scale. J Am Geriatr Soc (1968) 9.38
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med (2004) 8.60
Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol (2009) 8.55
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol (2009) 8.46
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol (2008) 7.89
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol (2006) 7.14
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med (2007) 7.05
Development and validation of a prognostic index for 4-year mortality in older adults. JAMA (2006) 6.79
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol (2013) 6.56
Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med (2004) 6.26
Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA (2004) 5.93
Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med (1997) 5.90
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial. Lancet Oncol (2009) 5.73
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Radiotherapy for glioblastoma in the elderly. N Engl J Med (2007) 5.64
Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med (2001) 5.43
Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ (2004) 5.34
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial. Lancet Oncol (2009) 5.05
The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc (2001) 4.99
Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc (2011) 4.98
Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med (2003) 4.90
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. J Clin Oncol (2009) 4.56
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol (2004) 4.46
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol (2008) 4.39
A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet (2011) 4.36
The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol (1981) 4.26
Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst (2000) 4.26
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol (2007) 4.19
The origins of age-related proinflammatory state. Blood (2004) 4.15
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol (2003) 4.06
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol (2008) 3.83
Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol (2007) 3.75
Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst (2001) 3.65
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol (2002) 3.53
The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc (2008) 3.51
Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol (2007) 3.50
Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci (2000) 3.45
Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol (2007) 3.44
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA (2005) 3.43
STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing (2008) 3.42
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst (2003) 3.41
Polypharmacy and prescribing quality in older people. J Am Geriatr Soc (2006) 3.39
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35
Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med (2008) 3.33
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition (1999) 3.28
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst (2006) 3.23
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol (2004) 3.18
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA (2009) 3.10
Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol (2006) 3.09
Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. J Clin Oncol (2004) 3.03
Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol (2010) 2.89
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med (2011) 13.74
Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol (2002) 9.83
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov (2011) 7.65
Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA (2009) 7.25
Age and acute myeloid leukemia. Blood (2006) 6.46
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. J Clin Oncol (2005) 5.27
Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy. J Clin Oncol (2010) 4.62
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J Clin Oncol (2008) 4.29
Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23
Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. J Clin Oncol (2009) 4.12
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol (2011) 4.07
Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol (2010) 3.78
Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70
Breast cancer treatment of older women in integrated health care settings. J Clin Oncol (2006) 3.46
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc Natl Acad Sci U S A (2014) 3.39
Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW: a randomized controlled trial. JAMA (2009) 3.37
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol (2014) 3.17
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst (2012) 3.16
Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol (2007) 3.06
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer. J Clin Oncol (2004) 3.03
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol (2005) 2.98
Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors. J Clin Oncol (2009) 2.97
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. J Clin Oncol (2012) 2.85
Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol (2006) 2.78
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study. J Clin Oncol (2012) 2.75
Screening for psychologic distress in ambulatory cancer patients. Cancer (2005) 2.74
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat (2011) 2.73
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Variation in patient-sharing networks of physicians across the United States. JAMA (2012) 2.59
Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med (2006) 2.58
Developing a cancer-specific geriatric assessment: a feasibility study. Cancer (2005) 2.57
Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat (2006) 2.55
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol (2005) 2.48
A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst (2011) 2.48
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. J Clin Oncol (2012) 2.45
Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol (2010) 2.45
Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg (2007) 2.43
The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc (2002) 2.42
Improving the quality of cancer care in an aging population: recommendations from an IOM report. JAMA (2013) 2.40
Non-small cell lung cancer. J Natl Compr Canc Netw (2012) 2.40
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol (2009) 2.33
Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med (2004) 2.31
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst (2011) 2.27
Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med (2004) 2.18
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18
Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer (2013) 2.14
Evidence-based risk communication: a systematic review. Ann Intern Med (2014) 2.14
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol (2014) 2.13
Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci (2007) 2.12
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer (2002) 2.10
Anemia and cancer in older persons. J Support Oncol (2007) 2.09
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Immune microenvironments in solid tumors: new targets for therapy. Genes Dev (2011) 2.08
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer (2003) 2.06
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol (2005) 2.06
Progress against solid tumors in danger: the metastatic breast cancer example. J Clin Oncol (2012) 2.05
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
Small cell lung cancer. J Natl Compr Canc Netw (2013) 2.04
Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw (2011) 2.03
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol (2007) 1.98
Blood pressure and survival in the oldest old. J Am Geriatr Soc (2007) 1.98
Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A (2011) 1.97
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer (2007) 1.94
Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol (2010) 1.93
The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer. Cancer (2003) 1.91
Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis. Adv Ther (2013) 1.90
Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys (2013) 1.89
The role of primary care physicians in cancer care. J Gen Intern Med (2009) 1.87
Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol (2003) 1.85
A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85
Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol (2003) 1.83
Explaining racial differences in prostate cancer mortality. Cancer (2012) 1.82
Improving quality of care for urban older people with diabetes mellitus and cardiovascular disease. J Am Geriatr Soc (2007) 1.80
Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: a Cancer and Leukemia Group B study. J Clin Oncol (2002) 1.80
Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res (2011) 1.78
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens. Arch Intern Med (2011) 1.77
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med (2015) 1.76
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol (2011) 1.76
Medicare Part D and nursing home residents. J Am Geriatr Soc (2007) 1.74
Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol (2009) 1.74
Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients. Health Aff (Millwood) (2008) 1.70
Mapping physician networks with self-reported and administrative data. Health Serv Res (2011) 1.70
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol (2008) 1.69